414 related articles for article (PubMed ID: 25495724)
1. Biocatalytic route to chiral acyloins: P450-catalyzed regio- and enantioselective α-hydroxylation of ketones.
Agudo R; Roiban GD; Lonsdale R; Ilie A; Reetz MT
J Org Chem; 2015 Jan; 80(2):950-6. PubMed ID: 25495724
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
Roiban GD; Agudo R; Reetz MT
Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
[TBL] [Abstract][Full Text] [Related]
3. CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity.
Roiban GD; Agudo R; Ilie A; Lonsdale R; Reetz MT
Chem Commun (Camb); 2014 Nov; 50(92):14310-3. PubMed ID: 25168091
[TBL] [Abstract][Full Text] [Related]
4. Regio- and stereoselective hydroxylation of 10-undecenoic acid with a light-driven P450 BM3 biocatalyst yielding a valuable synthon for natural product synthesis.
Kato M; Nguyen D; Gonzalez M; Cortez A; Mullen SE; Cheruzel LE
Bioorg Med Chem; 2014 Oct; 22(20):5687-91. PubMed ID: 24938497
[TBL] [Abstract][Full Text] [Related]
5. P450(BM3) on steroids: the Swiss Army knife P450 enzyme just gets better.
Wong LL
Chembiochem; 2011 Nov; 12(17):2537-9. PubMed ID: 21998091
[TBL] [Abstract][Full Text] [Related]
6. Evolving P450pyr Monooxygenase for Regio- and Stereoselective Hydroxylations.
Yang Y; Li Z
Chimia (Aarau); 2015; 69(3):136-41. PubMed ID: 26507217
[TBL] [Abstract][Full Text] [Related]
7. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution.
Kille S; Zilly FE; Acevedo JP; Reetz MT
Nat Chem; 2011 Aug; 3(9):738-43. PubMed ID: 21860465
[TBL] [Abstract][Full Text] [Related]
8. P450 BM3-Catalyzed Regio- and Stereoselective Hydroxylation Aiming at the Synthesis of Phthalides and Isocoumarins.
Holec C; Hartrampf U; Neufeld K; Pietruszka J
Chembiochem; 2017 Apr; 18(7):676-684. PubMed ID: 28107587
[TBL] [Abstract][Full Text] [Related]
9. Are branched chain fatty acids the natural substrates for P450(BM3)?
Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dynamics and QM/MM Calculations Predict the Substrate-Induced Gating of Cytochrome P450 BM3 and the Regio- and Stereoselectivity of Fatty Acid Hydroxylation.
Dubey KD; Wang B; Shaik S
J Am Chem Soc; 2016 Jan; 138(3):837-45. PubMed ID: 26716578
[TBL] [Abstract][Full Text] [Related]
11. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
[TBL] [Abstract][Full Text] [Related]
12. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution.
Agudo R; Roiban GD; Reetz MT
Chembiochem; 2012 Jul; 13(10):1465-73. PubMed ID: 22711296
[TBL] [Abstract][Full Text] [Related]
13. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
[TBL] [Abstract][Full Text] [Related]
14. Combined photoredox/engineered P450 enzymatic direct dioxygen-functionalization of arylalkanes to chiral acyloins.
Wang J; Wang H; Wei C; Zhang L; Cui B; Wang Z; Zhang Y; Wan N; Aisa HA; Chen Y
Org Biomol Chem; 2022 Nov; 20(46):9085-9092. PubMed ID: 36354366
[TBL] [Abstract][Full Text] [Related]
15. An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1.
Seifert A; Antonovici M; Hauer B; Pleiss J
Chembiochem; 2011 Jun; 12(9):1346-51. PubMed ID: 21591046
[TBL] [Abstract][Full Text] [Related]
16. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
17. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
Peters MW; Meinhold P; Glieder A; Arnold FH
J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
[TBL] [Abstract][Full Text] [Related]
18. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
[TBL] [Abstract][Full Text] [Related]
19. P450 BM3 crystal structures reveal the role of the charged surface residue Lys/Arg184 in inversion of enantioselective styrene epoxidation.
Shehzad A; Panneerselvam S; Linow M; Bocola M; Roccatano D; Mueller-Dieckmann J; Wilmanns M; Schwaneberg U
Chem Commun (Camb); 2013 May; 49(41):4694-6. PubMed ID: 23589805
[TBL] [Abstract][Full Text] [Related]
20. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
